Effectiveness and safety of sorafenib 400 mg vs. 800 mg initial dose on survival in patients with advanced and intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.